Pernell Williams
Impact in
- Virology top 5%
- HIV Research and Treatment
-
- Malaria Research and Control
- Mosquito-borne diseases and control
Papers in
- Virology 2
- HIV Research and Treatment 2
-
- Respiratory viral infections research 2
- Influenza Virus Research Studies 2
- Journals
- The Lancet (2 papers)Science (2 papers)Nature Medicine (2 papers)The Lancet Respiratory Medicine (1 paper)Science Translational Medicine (1 paper)
- Partner nations
- United States
In The Last Decade
Pernell Williams
9 papers receiving 1.7k citations
Pernell Williams's Hit Papers
Peers
Comparison fields: 5 of 64
- Virology 121
- Public Health, Environmental and Occupational Health 719
- Infectious Diseases 265
- Epidemiology 309
- Immunology 179
Countries citing papers authored by Pernell Williams
This map shows the geographic impact of Pernell Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pernell Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pernell Williams more than expected).
Fields of papers citing papers by Pernell Williams
This network shows the impact of papers produced by Pernell Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pernell Williams. The network helps show where Pernell Williams may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine Hit paper breakdown → | 2013 | 635 |
| 2 | A proof of concept for structure-based vaccine design targeting RSV in humans Hit paper breakdown → | 2019 | 282 |
| 3 | Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials Hit paper breakdown → | 2017 | 255 |
| 4 | Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial Hit paper breakdown → | 2022 | 135 |
| 5 | 2019 | 101 | |
| 6 | 2019 | 89 | |
| 7 | 2023 | 73 | |
| 8 | 2022 | 71 | |
| 9 | 2021 | 56 |
About Pernell Williams
Pernell Williams is a scholar working on Virology, Epidemiology, Infectious Diseases, Public Health, Environmental and Occupational Health and Radiology, Nuclear Medicine and Imaging, having authored 9 papers that have together received 1.7k indexed citations. Recurring topics across this work include HIV Research and Treatment (2 papers), Respiratory viral infections research (2 papers), Influenza Virus Research Studies (2 papers), Monoclonal and Polyclonal Antibodies Research (1 paper), Viral Infections and Outbreaks Research (1 paper), Malaria Research and Control (1 paper), Mosquito-borne diseases and control (1 paper) and SARS-CoV-2 and COVID-19 Research (1 paper). The work is most often cited by research in Virology (121 citations), Public Health, Environmental and Occupational Health (719 citations), Infectious Diseases (265 citations), Epidemiology (309 citations) and Immunology (179 citations). Pernell Williams has collaborated with scholars based in United States. Their work appears in journals such as The Lancet, Science, Nature Medicine, The Lancet Respiratory Medicine and Science Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.